arrow
C

Chien-Chung Lin

department of internal medicine, national cheng kung university hospital, college of medicine, national cheng kung university, tainan, taiwan
H指数:35
被引数:4,128

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Assessing time to symptomatic progression, a patient-relevant efficacy endpoint, in the MARIPOSA study in non-small cell lung cancer

评估MARIPOSA研究中非小细胞肺癌患者症状进展时间这一患者相关的疗效终点

2026-07-090
OA
Patient-Relevant Outcomes From the Phase III MARIPOSA-2 Trial: Amivantamab-Chemotherapy Versus Chemotherapy in EGFR-Mutant Advanced Non-Small-Cell Lung Cancer Following Disease Progression on Osimertinib
2025-12-200
PRE
Multivariable model for predicting 5-year survival in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective study

EGFR突变非小细胞肺癌患者接受EGFR酪氨酸激酶抑制剂治疗后5年生存率的预测多变量模型:一项回顾性研究

2025-03-140
OA
The Effectiveness and Safety of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients With Stage III/IV: A Multicenter Study
2021-07-072
OAAI
Sub-multiplicative interaction between polygenic risk score and household coal use in relation to lung adenocarcinoma among never-smoking women in Asia
2021-02-0115
OAAI